a surrogate-based approach for post-genomic partner identificationsurrogate-based方法后基因伙伴识别.pdfVIP

下载本文档

1
0
约5.84万字
约 9页
2017-09-11 发布于上海
举报
版权申诉

a surrogate-based approach for post-genomic partner identificationsurrogate-based方法后基因伙伴识别.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

a surrogate-based approach for post-genomic partner identificationsurrogate-based方法后基因伙伴识别

BMC Biotechnology BioMed Central BMC Biotechnology :6 2001, 1 Research article A surrogate-based approach for post-genomic partner identification †1 1 1 2 Renuka C Pillutla , Ku-chuan Hsiao† , Renee Brissette , Paul S Eder , 2 1 1 1 Tony Giordano , Paul W Fletcher , Michael Lennick , Arthur J Blume and Neil I Goldstein*1 Address: 1DGI BioTechnologies, Inc., Edison NJ, USA and 2Message Pharmaceuticals, Inc., Malvern, USA E-mail: Renuka C Pillutla - pillutla@; Ku-chuan Hsiao - hsiaok@; Renee Brissette - reab@; Paul S Eder - eder@; Tony Giordano - giordano@; Paul W Fletcher - pwfletcher@; Michael Lennick - mlennick@; Arthur J Blume - ablume@; Neil I Goldstein* - goldstein@ *Corresponding author †Contributed equally Published: 25 September 2001 Received: 16 July 2001 Accepted: 25 September 2001 BMC Biotechnology 2001, 1:6 This article is available from: /1472-6750/1/6 © 2001 Pillutla et al; licensee BioMed Central Ltd. Verbatim copying and redistribution of this article are permitted in any medium for any non-com- mercial purpose, provided this notice is preserved along with the articles original URL. For commercial use, contact info@ Abstract Background: Modern drug discovery is concerned with identification and validation of novel protein targets from among the 30,000 genes or more postulated to be present in the human genome